Research output per year
Research output per year
Fingerprint
Dive into the research topics where Brian Jonas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
Rosenberg, A. S., Brunson, A., Tuscano, J., Jonas, B., Hoeg, R., Wun, T. & Keegan, T. H. M., Jan 2021, In: Blood cancer journal. 11, 1, 5.Research output: Contribution to journal › Article › peer-review
Open Access -
Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center
Tenold, M. E., Moskoff, B. N., Benjamin, D. J., Hoeg, R., Rosenberg, A. S., Abedi, M., Tuscano, J. & Jonas, B., Mar 11 2021, In: Frontiers in Oncology. 11, 649209.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia
Jonas, B., Fisch, S. C., Rosenberg, A. S., Hoeg, R., Tuscano, J. & Abedi, M., Apr 1 2021, In: American Journal of Hematology. 96, 4, p. E114-E117Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center
Tenold, M. E., Moskoff, B. N., Krishnan, R., Rosenberg, A. S., Hoeg, R., Abedi, M., Tuscano, J. & Jonas, B., 2021, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article › peer-review
-
A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies
Hoeg, R. T., Davis, J., Jonas, B. A., Tuscano, J., Rosenberg, A. & Abedi, M., Jan 1 2020, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article › peer-review